Xenon Pharmaceuticals (XENE) Deferred Taxes (2018 - 2026)
Xenon Pharmaceuticals (XENE) reported Deferred Taxes of $447000.0 for Q1 2026, up 136.85% year-over-year from $188726.4 in Q1 2025, and up 140.13% quarter-over-quarter from -$1.1 million in Q4 2025.
Xenon Pharmaceuticals (XENE) Deferred Taxes (2018 - 2026) Analysis & Trends
Xenon Pharmaceuticals (XENE) has 9 years of Deferred Taxes data on file, last reported at $447000.0 in Q1 2026.
- Deferred Taxes for Q1 2026 came in at $447000.0, up 136.85% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.5 million (up 85.32% YoY), and the FY2025 annual result was -$3.2 million, up 63.92% from the prior year.
- Deferred Taxes advanced to $447000.0 in Q1 2026 per XENE's latest filing, from -$1.1 million in the prior quarter.
- Over five years, Deferred Taxes peaked at $447000.0 in Q1 2026 and troughed at -$8.6 million in Q4 2024.
- A 5-year average of -$703000.0 and a median of -$200000.0 in 2023 frame the typical range for Deferred Taxes.
- The sharpest annual moves came in 2022 and 2024: Deferred Taxes soared 2766.67% in 2022, then plunged 4206.0% in 2024.
- A 5-year view of Deferred Taxes shows it stood at $5000.0 in 2022, then slumped by 4100.0% to -$200000.0 in 2023, then sank by 4206.0% to -$8.6 million in 2024, then soared by 87.06% to -$1.1 million in 2025, then surged by 140.13% to $447000.0 in 2026.
- Business Quant data shows XENE's Deferred Taxes at $447000.0 in Q1 2026, -$1.1 million in Q4 2025, and -$701000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -65.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Xenon Pharmaceuticals | 4.61 Bn | 4.61 Bn | - | 447,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 447,000.00 |
| Dec 31, 2025 | -1.11 Mn |
| Sep 30, 2025 | -701,000.00 |
| Jun 30, 2025 | -170,000.00 |
| Mar 31, 2025 | -1.21 Mn |
| Dec 31, 2024 | -8.61 Mn |
| Sep 30, 2024 | -322,000.00 |
| Jun 30, 2024 | -333,000.00 |
| Mar 31, 2024 | 403,000.00 |
| Dec 31, 2023 | -200,000.00 |
| Sep 30, 2023 | -156,000.00 |
| Jun 30, 2023 | -224,000.00 |
| Mar 31, 2023 | 288,000.00 |
| Dec 31, 2022 | 5,000.00 |
| Sep 30, 2022 | -203,000.00 |
| Jun 30, 2022 | -104,000.00 |
| Mar 31, 2022 | 258,000.00 |
| Dec 31, 2021 | 346,000.00 |
| Sep 30, 2021 | -267,000.00 |
| Jun 30, 2021 | -30,000.00 |